Stockreport

Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference

Immuneering Corporation - Class A  (IMRX) 
PDF CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and commercialize mor [Read more]